SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer

摘要

The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases.